Literature DB >> 6496330

The heart in massive (more than 300 pounds or 136 kilograms) obesity: analysis of 12 patients studied at necropsy.

C A Warnes, W C Roberts.   

Abstract

Observations are described in 12 massively obese patients (5 women, 7 men), aged 25 to 59 years (mean 37), who weighed 312 to more than 500 pounds (mean 381). Seven patients had had systemic hypertension, 4 hypersomnia or sleep apnea, 2 diabetes mellitus, and 1 patient symptomatic coronary artery disease. Five patients died suddenly from undetermined causes, 2 from right-sided congestive heart failure, 1 patient from acute myocardial infarction; 1 from aortic dissection; 1 from intracerebral hemorrhage; 1 from a drug overdose, and 1 soon after an ileal bypass. The heart weight was increased in all 12 patients. The heart weight to body weight ratio expressed as a percent ranged from 0.22 to 0.61 (mean 0.37) (normal for men 0.42 to 0.46 [mean 0.43], normal for women 0.38 to 0.46 [mean 0.40]). The left ventricular cavity was dilated in 11 patients and the right ventricular cavity in all 12. Only 2 patients (aged 42 and 59 years) had 1 or more major epicardial coronary arteries narrowed greater than 75% in cross-sectional area by atherosclerotic plaque, 1 of whom had no symptoms of myocardial ischemia. Of 664 five-millimeter segments from the 4 major epicardial coronary arteries from 11 patients (mean 60 per patient), 431 (65%) were narrowed 0 to 25% in XSA, 143 (21%) were narrowed 26 to 50%, 73 (11%) were narrowed 51 to 75%, and 17 (3%) were narrowed 76 to 100%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6496330     DOI: 10.1016/s0002-9149(84)80149-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Heart failure and obesity in adults: pathophysiology, clinical manifestations and management.

Authors:  Martin A Alpert; Harsh Agrawal; Kul Aggarwal; Senthil A Kumar; Arun Kumar
Journal:  Curr Heart Fail Rep       Date:  2014-06

2.  William Clifford Roberts, MD: an interview by W. Bruce Fye, MD.

Authors:  William C Roberts; W Bruce Fye
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

Review 3.  Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.

Authors:  Martin A Alpert; Jad Omran; Brian P Bostick
Journal:  Curr Obes Rep       Date:  2016-12

Review 4.  Cardiomyocyte apoptosis in animal models of obesity.

Authors:  Premal S Trivedi; Lili A Barouch
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 5.  Challenges in cardiac risk assessment in bariatric surgery patients.

Authors:  David Gugliotti; Paul Grant; Wael Jaber; Loutfi Aboussouan; Charles Bae; Daniel Sessler; Philip Scahuer; Roop Kaw
Journal:  Obes Surg       Date:  2007-12-08       Impact factor: 4.129

6.  Lower extremity edema and pulmonary hypertension in morbidly obese patients with obstructive sleep apnea.

Authors:  Daniel J O'Hearn; Avram R Gold; Morris S Gold; Paul Diggs; Steven M Scharf
Journal:  Sleep Breath       Date:  2008-07-10       Impact factor: 2.816

Review 7.  The Impact of Obesity on Critical Illnesses.

Authors:  Itay Ayalon; Lauren Bodilly; Jennifer Kaplan
Journal:  Shock       Date:  2021-11-01       Impact factor: 3.454

8.  Inhibition of inflammation and oxidative stress by an imidazopyridine derivative X22 prevents heart injury from obesity.

Authors:  Yuanyuan Qian; Yali Zhang; Peng Zhong; Kesong Peng; Zheng Xu; Xuemei Chen; Kongqin Lu; Gaozhi Chen; Xiaokun Li; Guang Liang
Journal:  J Cell Mol Med       Date:  2016-03-28       Impact factor: 5.310

9.  Study of the effect of obesity on QT-interval among adults.

Authors:  Tarun Kumar; Kamlesh Jha; Ashok Sharan; Pooja Sakshi; Shishir Kumar; Amita Kumari
Journal:  J Family Med Prim Care       Date:  2019-05

Review 10.  The Role of Brown Adipose Tissue Dysfunction in the Development of Cardiovascular Disease.

Authors:  Hong-Jin Chen; Ting Meng; Ping-Jin Gao; Cheng-Chao Ruan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.